Chemoinformaics analysis of 6alpha-Hydroxybuphanisine
| Molecular Weight | 301.342 | nRot | 1 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 23 |
| Exact Molecular Weight | 301.131 | nRing | 5 |
| Solubility: LogS | -1.631 | nHRing | 3 |
| Solubility: LogP | 0.997 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 45.3671 |
| nHD | 1 | BPOL | 25.9789 |
| QED | 0.8 |
| Synth | 5.201 |
| Natural Product Likeliness | 2.669 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.994 |
| HIA | 0.005 |
| CACO-2 | -4.872 |
| MDCK | 0.000016 |
| BBB | 0.982 |
| PPB | 0.609503 |
| VDSS | 1.714 |
| FU | 0.373304 |
| CYP1A2-inh | 0.349 |
| CYP1A2-sub | 0.658 |
| CYP2c19-inh | 0.091 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.063 |
| CYP2c9-sub | 0.496 |
| CYP2d6-inh | 0.601 |
| CYP2d6-sub | 0.539 |
| CYP3a4-inh | 0.789 |
| CYP3a4-sub | 0.804 |
| CL | 6.403 |
| T12 | 0.524 |
| hERG | 0.094 |
| Ames | 0.344 |
| ROA | 0.445 |
| SkinSen | 0.183 |
| Carcinogencity | 0.356 |
| EI | 0.011 |
| Respiratory | 0.912 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.694117 |